ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.45 Cr | ₹25 Cr | ₹20 Cr | ₹29 Cr | ₹33 Cr |
What is the latest Contingent Liabilities ratio of ANUH PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹7.45 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹33 Cr |
How is Contingent Liabilities of ANUH PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.45 Cr | -70.49 | |
| Mar2025 | ₹25 Cr | 24.50 | |
| Mar2024 | ₹20 Cr | -30.61 | |
| Mar2023 | ₹29 Cr | -11.19 | |
| Mar2022 | ₹33 Cr | - | |
Compare Contingent Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹836.6 Cr | 2.4% | -7.4% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 2.4% |
-7.4% |
6% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses